BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/26/2024 8:29:41 AM | Browse: 65 | Download: 166
 |
Received |
|
2024-01-20 02:02 |
 |
Peer-Review Started |
|
2024-01-20 02:02 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-06-08 03:16 |
 |
Revised |
|
2024-06-26 01:42 |
 |
Second Decision |
|
2024-07-05 02:36 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-07-05 08:10 |
 |
Articles in Press |
|
2024-07-05 08:10 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-07-09 00:54 |
 |
Publish the Manuscript Online |
|
2024-07-26 08:29 |
ISSN |
2222-0682 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Ophthalmology |
Manuscript Type |
Minireviews |
Article Title |
Pharmacological adjuvants for diabetic vitrectomy surgery
|
Manuscript Source |
Invited Manuscript |
All Author List |
Ramesh Venkatesh, Chaitra Jayadev, Vishma Prabhu, Priyanka Gandhi, Rupal Kathare, Naresh K Yadav, Ayushi Choudhary and Jay Chhablani |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Ramesh Venkatesh, MBBS, MD, MS, Doctor, Doctor, Surgeon, Department of Ophthalmology, Narayana Nethralaya, 121/C. 1st R block, West of Chord Road, Rajaji Nagar, Bangalore 560010, India. vramesh80@yahoo.com |
Key Words |
Diabetic retinopathy; Vitrectomy; Intravitreal injections; Anti-vascular endothelial growth factor; Adjuvants; Outcomes |
Core Tip |
For advanced diabetic retinopathy, diabetic vitrectomy is a complex procedure with unpredictable outcomes. In the last decade, intravitreal pharmacotherapy has advanced, providing new ways to improve surgical outcomes for our patients. In medicine, an "adjunct" refers to a drug or substance that supplements the main treatment. This review will look at the pharmacological adjuncts used in diabetic vitrectomy surgery and how they affect specific steps. The categorization system enables surgeons to anticipate surgical issues and select the appropriate pharmacological agent to address them, thereby increasing surgical success rates. |
Publish Date |
2024-07-26 08:29 |
Citation |
<p>Venkatesh R, Jayadev C, Prabhu V, Gandhi P, Kathare R, Yadav NK, Choudhary A, Chhablani J. Pharmacological adjuvants for diabetic vitrectomy surgery. <i>World J Methodol</i> 2024; 14(4): 92246</p> |
URL |
https://www.wjgnet.com/2222-0682/full/v14/i4/92246.htm |
DOI |
https://dx.doi.org/10.5662/wjm.v14.i4.92246 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345